Precision Medicine Collaboration and Licensing Deals 2016-2023

$3,995.00

Precision Medicine Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2023

Publication date
November 2023
Number of pages
900+
Product type
Research report
Available formats
PDF document
Report edition
4
SKU
CP2108

Precision Medicine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the precision medicine deals entered into by the worlds leading biopharma companies.

Fully revised and updated, the report provides details of precision medicine deals from 2016 to 2023.

The report provides a detailed understanding and analysis of how and why companies enter precision medicine deals. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. 

The report includes collaboration, development, research and licensing deals.

This report contains a comprehensive listing of 1699 precision medicine deals announced since 2016 including financial terms where available including links to online deal records of actual precision medicine partnering deals as disclosed by the deal parties. In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners.

The initial chapters of this report provide an orientation of precision medicine dealmaking. 

Chapter 1 provides an introduction to the report.

Chapter 2 provides an overview of the trends in precision medicine dealmaking since 2016.

Chapter 3 provides an overview of the leading precision medicine deals since 2016. Deals are listed by headline value.

Chapter 4 provides a comprehensive listing of the top 25 most active companies in precision medicine dealmaking with a brief summary followed by a comprehensive listing of precision medicine deals, as well as contract documents available in the public domain.

Chapter 5 provides a comprehensive and detailed review of precision medicine deals signed and announced since Jan 2016, where a contract document is available in the public domain. 

Chapter 6 provides a comprehensive and detailed review of precision medicine partnering deals signed and announced since Jan 2016. The chapter is organized by specific precision medicine technology type in focus.

The report also includes numerous table and figures that illustrate the trends and activities in precision medicine deal making since 2016.

In addition, a comprehensive deal directory is provided organized by company A-Z, deal type and therapeutic target. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

Key benefits

Precision Medicine Collaboration and Licensing Deals provides the reader with the following key benefits:

•    Understand deal trends since 2016
•    Browse precision medicine collaboration and licensing deals
•    Benchmark analysis – identify market value of transactions
•    Financials terms - upfront, milestone, royalties
•    Directory of deals by company A-Z, deal type and therapy area
•    Leading deals by value
•    Most active dealmakers
•    Identify assets and deal terms for each transaction
•    Access contract documents - insights into deal structures
•    Due diligence - assess suitability of your proposed deal terms for partner companies
•    Save hundreds of hours of research time

Report scope

Precision Medicine Collaboration and Licensing Deals is intended to provide the reader with an in-depth understanding of precision medicine trends and structure of deals entered into by leading biopharma companies worldwide.

Precision Medicine Collaboration and Licensing Deals includes:
•    Trends in precision medicine dealmaking in the biopharma industry
•    Directory of precision medicine deal records covering pharmaceutical and biotechnology
•    The leading precision medicine deals by value
•    Most active precision medicine licensing dealmakers

Precision Medicine Collaboration and Licensing Deals provides comprehensive access to available records for deals, including contract documents where available.

Analyzing contract agreements allows due diligence of:

•    What are the precise rights granted or optioned?
•    What is actually granted by the agreement to the partner company?
•    What exclusivity is granted?
•    What is the payment structure for the deal?
•    How are sales and payments audited?
•    What is the deal term?
•    How are the key terms of the agreement defined?
•    How are IPRs handled and owned?
•    Who is responsible for commercialization?
•    Who is responsible for development, supply, and manufacture?
•    How is confidentiality and publication managed?
•    How are disputes to be resolved?
•    Under what conditions can the deal be terminated?
•    What happens when there is a change of ownership?
•    What sublicensing and subcontracting provisions have been agreed?
•    Which boilerplate clauses does the company insist upon?
•    Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
•    Which jurisdiction does the company insist upon for agreement law?

Precision Medicine Collaboration and Licensing Deals provides the reader with the following key benefits:

•    Understand deal trends since 2016
•    Browse precision medicine collaboration and licensing deals
•    Benchmark analysis – identify market value of transactions
•    Financials terms - upfront, milestone, royalties
•    Directory of deals by company A-Z, deal type and therapy area
•    Leading deals by value
•    Most active dealmakers
•    Identify assets and deal terms for each transaction
•    Access contract documents - insights into deal structures
•    Due diligence - assess suitability of your proposed deal terms for partner companies
•    Save hundreds of hours of research time

Executive Summary

Chapter 1 – Introduction

Chapter 2 – Trends in precision medicine dealmaking
2.1. Introduction
2.2. Precision medicine deals over the years
2.3. Most active precision medicine dealmakers
2.4. Precision medicine deals by deal type
2.5. Precision medicine deals by therapy area
2.6. Precision medicine deals by industry sector
2.7. Deal terms for precision medicine deals
2.7.1 Precision medicine deals headline values
2.7.2 Precision medicine deal upfront payments
2.7.3 Precision medicine deal milestone payments
2.7.4 Precision medicine royalty rates

Chapter 3 – Leading precision medicine deals
3.1. Introduction
3.2. Top precision medicine deals by value

Chapter 4 – Most active precision medicine dealmakers
4.1. Introduction
4.2. Most active precision medicine dealmakers
4.3. Most active precision medicine deals company profiles

Chapter 5 – Precision medicine contracts dealmaking directory
5.1. Introduction
5.2. Precision medicine contracts dealmaking directory

Chapter 6 – Precision medicine dealmaking by technology type

Deal directory

Deal directory – Precision medicine deals by company A-Z
Deal directory – Precision medicine deals by deal type
Deal directory – Precision medicine deals by therapy area

Deal type definitions

About Wildwood Ventures    
Current Partnering
Current Agreements
Recent report titles from Current Partnering



Table of figures

Figure 1: Precision medicine deals since 2016
Figure 2: Active precision medicine dealmaking activity – 2016 - 2023
Figure 3: Precision medicine deals by deal type since 2016
Figure 4: Precision medicine deals by therapy area since 2016
Figure 5: Precision medicine deals by industry sector since 2016
Figure 6: Precision medicine deals with a headline value
Figure 7: Precision medicine deals with an upfront value
Figure 8: Precision medicine deals with a milestone value
Figure 9: Precision medicine deals with a royalty rate value
Figure 10: Top precision medicine deals by value since 2016
Figure 11: Most active precision medicine dealmakers 2016 - 2023
Figure 12: Precision medicine deals by technology type since 2016

Pricing options

  • $3,995: single-user (encrypted file - one user/device)
  • $5,995: multi-user (encrypted file - up to 5 users/devices)
  • $9,995: company (unencrypted file)

Single and Multi-user license files are encrypted PDF documents. Details of how to access using Javelin3 PDF Reader will be provided at report delivery.

Company license files are not encrypted and can be accessed using a PDF Reader.

A full explanation of license type definitions can be found here.

 

Our guarantee

 

Price promise

We guarantee our prices are competitive. If you find the same report advertised at a lower price within 7 days of purchase, we will refund the difference.

 

Delivery Deadline

We guarantee that the report will be sent within the specified delivery times. In the unlikely case of a delay we may offer a partial refund as compensation. (Terms may apply)

 

Latest report

If an update is published within 30 days of your purchase, you will receive it absolutely free of charge.

 

Serious Security

We take your data and security seriously. See our privacy policy for details of how we manage your data.

All card payments are processed by Evalon.

 

Sales Support

If you have any questions about your report or are unhappy with the quality, we will do our best to resolve your query. Contact us direct.

 

Total Trust

Current Partnering is part of Wildwood Ventures Ltd., based in York, United Kingdom. We have been trading successfully online since 2009 and work with some of the most famous brands in the business. We carefully select our partners to ensure that the publications meet expectations of demanding customers.

1CellBiO, 2bPrecise, 2cureX, 2seventy bio, 2X Oncology, 3 Sisters Surrogacy, 3D Systems, 4baseCare, 4bases, 4D Molecular Therapeutics, 4D Path, 10X Genomics, 22nd Century, 23andMe, 48Hour Discovery, A*STAR Agency for Science, Technology and Research, A*STAR Bioinformatics Institute, A*STAR Bioprocessing Technology Institute, A*STAR Genome Institute of Singapore, A*STAR Singapore Immunology Network, A2 Biotherapeutics, Abbott Laboratories, Abbvie, Abcam, AbCellera Biologics, AbFero Pharmaceuticals, ABL Bio, Abramson Cancer Center, Absorption Systems, Academia Sinica, Academic Medical Center, Accelerated Cure Project for MS, Accelerate Technologies, AccessDx Laboratory, Access to Comprehensive Genomic Profiling Coalition, AccuGenomics, AccuStem Sciences, Acerta Pharma, Achilles Therapeutics, AC Immune, Aclipse Therapeutics, Acrobat Genomics, Active Motif, Adaptive Biotechnologies, Adaptive Phage Therapeutics, ADC Therapeutics, Addario Lung Cancer Medical Institute, Adial Pharmaceuticals, ADInstruments, Adlai Nortye, Admera Health, Adrestia, Aduro BioTech, Advanced Cell Diagnostics, Advanced Nuclear Medicine Ingredients, Advaxis, AdventHealth, Aelan Cell Technologies, AESOP Technology, Aevi Genomic Medicine, Affigen, AgBiome, Age Labs, Agendia, Agilent Technologies, Agios Pharmaceuticals, Agribody Technologies, Agriplex Genomics, AHN Autoimmunity Institute, AIkido Pharma, AimedBio, Aitbiotech, Akadeum Life Sciences, Akoya Biosciences, Albany Molecular Research, Albert Einstein College of Medicine, Alcedis, Alchemab, Alcyone Lifesciences, Alector, Alexion Pharmaceuticals, All4Cure, Allarity Therapeutics, AllCells, Allegheny General Hospital, Alligator Bioscience, Alloy Therapeutics, Allscripts, Almac Diagnostics, Almac Group, Alnylam Pharmaceuticals, Alphageneron Pharmaceuticals, Alpha Genomix Laboratories, Alto Neuroscience, Altor BioScience, Alyatec, Alzheimer's Drug Discovery Foundation, Amazon Web Services, Ambry Genetics, American Association of Neuromuscular & Electrodiagnostic Medicine, American Lung Association, American Physiological Society, American Skin Association, American Society of Clinical Oncology (ASCO), American Type Culture Collection (ATCC), Amerimmune, Amgen, Amoy Diagnostics, Amplicon Express, AMRA, AMRA Medical, Amydis, Analytical BioSciences, Analytics Engines, Angers University, Angsana Molecular & Diagnostics, AnHeart Therapeutics, Anivive Lifesciences, Apocell, Appistry, Applied Biosystems, Applied DNA Sciences, Aptorum Group, Arbor Biosciences, Arbor Biotechnologies, ArcherDX, ARCHIMEDlife, Arcis Biotechnology, Arcturus Therapeutics, Arcus Biosciences, Arena Pharmaceuticals, Ares Genetics, Ares Life Sciences, Ariadne Genomics, Ariana Pharma, AriBio, Ariel Precision Medicine, Arima Genomics, Arizona State University, AroCell, Artialis, Artios Pharma, ARUP Laboratories, Arvinas, Asa Ren, Ashvattha Therapeutics, Aslan Pharma, Assistance Publique-Hôpitaux de Paris, Associazione Poic e Dintorni APS, Assurex Health, Assuta Medical Centers, Astellas Pharma, Asterand Bioscience, Asthma UK, AstraZeneca, Asuragen, ATAI Life Sciences, Atara Biotherapeutics, Atlas Antibodies, Atreca, ATUM, AUM Biosciences, Aural Analytics, Auria Biobank, Australian Research Data Commons, Avance Biosciences, Avatamed, AVEO Oncology, Avera Health, Avera Heart Hospital of South Dakota, Avidity Biosciences, AXIM Biotechnologies, AyoxxA Biosystems, B-MoGen Biotechnologies, Baheal Pharmaceutical, Bank of America, Banner Health, Banyan Biomarkers, Basepair, Basepaws, BASF, Battelle, Baxalta, Baxter International, Bayer, Bayer CropScience, Baylor College, Baylor College of Medicine, Baylor Genetics, Baylor Miraca Genetics Laboratories, Baylor Scott and White Research Institute, BC Cancer Agency, BC Platforms, Beacon Biosignals, Becton Dickinson, BeiGene, Beijing Genomics Institute (BGI), Beijing Xisike Clinical Oncology Research Foundation, BenevolentAI, Benson Hill Biosystems, Berg, Berkeley Lights, Berry Genomics, Beth Israel Deaconess Medical Center, BGI, Bill and Melinda Gates Foundation, Bio-Medical Science, Bio-Rad Laboratories, Bio-Techne, BioArctic Neuroscience, BioBright, Biocartis, Biocept, Biocodices, Biodesix, BioDiscovery, Biofidelity, Biogen, Biogenar, Biogenysis, Biognosys, BioIntelliSense, BioLegend, BioLizard, BioLum Sciences, BioMap, BioMarin Pharmaceutical, Biomarker Collaborative, BioMarker Strategies, Biomedical Advanced Research and Development Authority, Biomedix, BioMed X Innovation Center, bioMerieux, Biomillenia, BiomX, BioNano Genomics, Bionomics, BioNTech, BioReference Laboratories, Biosearch Technologies, BioSkryb, Biosplice, Biotest, BioTheranostics, Biothera Pharmaceuticals, Bioyong, Bioz, Bird Foundation, BitBiome, Blackfynn, BlackThorn Therapeutics, Blinktbi, Bliss Biopharmaceutical, Blockchain Global, Blu Biotech, Bluebee, Bluebird Bio, Blue Cross Blue Shield Association, BluePen Biomarkers, Blueprint Genetics, Blueprint Medicines, BlueRock Therapeutics, Boca Biolistics, Boehringer Ingelheim, Bonnie J. Addario Lung Cancer Foundation, Boreal Genomics, BostonGene, Boston University School of Medicine, Boston Veterans Affair Research Institute, Bpifrance, Brain Biomarker Solutions in Gothenburg, BRAINBox Solutions, BrainScope, Brain Trauma Foundation, Breath Diagnostics, Brenus Pharma, BriaCell Therapeutics, Brigham and Women's Hospital, BrightPath Biotherapeutics, Bristol-Myers Squibb, Bristol-Myers Squibb Pakistan, Broad Institute, Brown University, Buck Institute for Age Research, Buhler, Burning Rock, Busan Paik Hospital, C2i Genomics, C4X Discovery, California Institute for Biomedical Research, California Institute for Regenerative Medicine, California Institute of Technology, Calviri, Calyxt, Cambia Health Solutions, Cambridge Cancer Genomics, Cambridge Epigenetix, Cambridge Quantum Computing, CAMP4 Therapeutics, Canadian Cancer Society, Canadian Council, Canadian Institutes of Health Research, CANbridge Pharmaceuticals, Cancer Genetics, Cancer Molecular Diagnostic Laboratory, Cancer Research Horizons, Cancer Research Institute, Cancer Research UK, Canopy Biosciences, Cantabio Pharmaceuticals, Caprion Biosciences, Caraway Therapeutics, CareDx, Caribou Biosciences, Carina Biotech, Caris Life Sciences, Carmentix, Carolina BioOncology Institute, Cartana, CarThera, CARTI Cancer Center, Case Western Reserve University, CASI Pharmaceuticals, CasZyme, Catholic University Leuven, CBD Solutions, Cedars-Sinai Medical Center, Celemics, Celgene, Cell and Gene Therapy Catapult, Cellaria Biosciences, CellChorus, Cellecta, Cellkey, Cell Medica, Cell Mogrify, Cellnetix, Cellworks, Celmatix, Celsius Therapeutics, Centene, Center for Aquaculture Technologies, Center for Biomarker Research in Medicine, Center for Forensic Science Research & Education, Center for Molecular Medicine, Centers for Disease Control and Prevention, Centogene, Centre for Commercialization of Regenerative Medicine (CCRM), Centre For Proteomic & Genomic Research, Centre for Research in Agricultural Genomics, Centre Leon Berard, Cerba Research, CerebraCell, Cergentis, Certainty Health, Certis, Cerveau Technologies, Ceva Sante Animale, CFTechnology.org, CGA 369, Champions Oncology, Chan Zuckerberg Initiative, Chao Center, Charcot-Marie-Tooth Association, Charite Universitatsmedizin Berlin, Charles River Laboratories, Chembio Diagnostics, Children's Hospital Boston, Children's Hospital Los Angeles, Children's Hospital of Orange County, Children's Hospital of Philadelphia, Children's Medical Research Institute, Children's Minnesota, Children's Research Institute, Children’s Center for Cancer and Blood Diseases (CCCBD), Children’s Hospital Oakland Research Institute (CHORI), Chinese Academy of Agricultural Science, Chinook Therapeutics, Christian Doppler Research Association, Chroma Medicine, Chugai Pharmaceutical, CHU Sainte-Justine, Cicero Diagnostics, Cipherome, Circuit Clinical, Circular Genomics, Circulogene, Citizens United for Research in Epilepsy, City of Hope, Clearbridge Biomedics, ClearLight Diagnostics, Cleveland Clinic, Cleveland Diagnostics, Clexio, Clinical Genomics, Clinical Outcomes Tracking and Analysis, Closed Loop Medicine, Cloudera, Clover Therapeutics, Clovis Oncology, CMT Research Foundation, Codexis, Codigo46, Cofactor Genomics, Cogia Biotech, Cognition Therapeutics, CogState, Cohen Veterans Bioscience, Color, Colorado Center for Personalized Medicine, Columbia University, Columbia University Medical Center, Combating Terrorism Technical Support Office, CombiGene, Companion Medical, Complete Genomics, Compugen, ConcertAI, Concert Genetics, Concr, Congenica, Contextual Genomics, COPD Foundation, CoreBiome, Coriell Life Sciences, Cornell University, Corning, Corteva Agriscience, COTA, Courtagen Life Sciences, Covance, Covaris, Critical Diagnostics, Crohn's and Colitis Foundation of America, Crossbeta Biosciences, Crown Bioscience, Cryostem, CSI Laboratories, Culmination Bio, Curable, CureMatch, CURE Pharmaceutical, CureScience, Curetis, Curis, CvergenX, Cyclerion Therapeutics, Cyclica, CYduct Diagnostics, Cystic Fibrosis Foundation, CYTOVIA Therapeutics, Cytox, Daiichi Sankyo, Dana-Farber Cancer Institute, Danish Cancer Society Research Center, Danish Center for Strategic Research into Type 2 Diabetes, Dante Genomics, Dante Labs, DarioHealth, Dartmouth-Hitchcock Medical Center, DaRui Biotech, DarwinHealth, DataRobot, Data Tecnica International, Datavant, Day One Biopharmaceuticals, Deargen, Debiopharm, Decipher Biosciences, Decode Health, DEEP 6 AI, Deep Genomics, Deep Longevity, Deerfield Management, Defense Advanced Research Projects Agency, Definiens, DefiniGEN, Delfi Diagnostics, Denali Therapeutics, Dendreon, Denka, Denka-KEW Genomics, Denovo Biopharma, Department of Health - Abu Dhabi, Department of Veterans Affairs, Desktop Genetics, DestiNA Genomics, Devyser Diagnostics, DHR Health, Diaceutics, DiamiR, Diamyd Medical, DIAN Diagnostics, Diatech Pharmacogenetics, Dicom Systems, Dimerix Biosciences, DiscoveRx, Divergence Neuro Technologies, Diversigen, DNA Link, DNAmito, DNAnexus, DNA Script, Dolomite Bio, DoMore Diagnostics, Dow AgroSciences, DrChrono, Duchenne UK, Duke-NUS Graduate Medical School Singapore, Duke University, Duke University Health System, Duke University Medical Center, DuPont, DuPont Pioneer, DxTerity, DxVx, e-NIOS, Eagle Genomics, Early Signal Foundation, Eccrine Systems, ECOG-ACRIN Cancer Research Group, Edico Genome, Editas Medicine, Eisai, Eisai Inc, Element Biosciences, Elevation Oncology, Eli Lilly, Elo Life Systems, Elsevier, Elucigene, Elysium Health, EMBRAPA, EMD Serono, Emedgene, Emendo Biotherapeutics, Emulate, EncrypGen, Endocanna Health, ENDRA Life Sciences, Enigma Biomedical, ENPICOM, Ensoma, Enterome Bioscience, Entheon Biomedical, Enzyvant Science, Eone-Diagnomics Genome Center, Epic, Epicore Biosystems, Epic Sciences, Epilepsy Society, Epinomics, Epivax, EpiVax Therapeutics, Epizyme, Erasmus University Medical Center, ERS Genomics, ErVimmune, Ethos Research & Development, Etubics, Eucure Biopharma, Euformatics, Eureka Eurostars, Eurofarma, Eurofins Genomics, Eurofins Scientific, Euroimmun, European Commission, European Equity Partners, European Organization for Research and Treatment of Cancer, European Union, Evaxion Biotech, Evogen, Evolva, Evonetix, Evotec, Evvy, Exactis Innovation, Exact Sciences, Exagen Diagnostics, Excelra, Exonics Therapeutics, Exosome Diagnostics, Exosome Sciences, Expesicor, Exploragen, ExScientia, ExxonMobil, F1 Oncology, Fabric Genomics, Factorial Biotechnologies, Factorial Diagnostics, Falco, FDNA, Feinstein Institute for Medical Research, Ferring Pharmaceuticals, Fertility SOURCE Companies, Fibrogen, Fight Colorectal Cancer, FinnGen, Firefly Neuroscience, First Databank, First Genetics JCS, FivepHusion, Five Prime Therapeutics, Flagship Biosciences, Flare Therapeutics, Flatiron Health, Florida Hospital, FlowJo, Flow Pharma, Fluent BioSciences, Fluidigm, FLX Bio, FMC, Food Allergy Research & Education, Food and Drug Administration (FDA), Forian, Fortis Life Sciences, Fortis Therapeutics, Foundation for Innovative New Diagnostics, Foundation for the Children of the Californias, Foundation for the National Institutes of Health (FNIH), Foundation Medicine, Fox Chase Cancer Center, FOXO Technologies, Fred Hutchinson Cancer Research Center, Freenome, French National Institute for Agricultural Research, Friends of Cancer Research, Frontage Laboratories, Front Range Biosciences, FSHD Global Research Foundation, Fudan University, Fujirebio Diagnostics, Fujitsu Laboratories, Fulcrum Therapeutics, Fulgent Genetics, Fundacion Progreso y Salud, Fusion Antibodies, Fusion Genomics, Fusion Pharmaceuticals, FYR Diagnostics, G+FLAS Life Sciences, G1 Therapeutics, G42 Healthcare, Gabriella Miller Kids First Data Resource Center, Galmed Pharmaceuticals, Ganymede Bio, GATC Health, Gateway for Cancer Research, GC Pharma, GDM Seeds, GEDmatch, Geisel School of Medicine at Dartmouth, Gemini Therapeutics, Gencove, GeneBay, GeneCentric Therapeutics, Genective, GeneData, GeneDX, Geneformics, GeneMatters, Genentech, GenePeeks, General Genomics, Geneseeq, Genestack, Genetica, Genetic Alliance, Genetic Technologies, Genetika+, Genetiks, Genetron Health, Geneva University Hospitals, Genewiz, Geneyx, Genialis, Genome BC, Genome Canada, GenomeDx, Genome Insight, Genome Institute of Singapore, Genome Medical, Genomenon, Genome Prairie, Genomes2People, Genomic Biopharma, Genomic Health, Genomics, Genomics England, Genomic Testing Cooperative, Genomic Vision, Genomind, Genomoncology, Genoox, GenoScreen, Genosity, Genovive, Genprex, GenScript Biotech, Genspace, Gentris, Genuity Science, Genus, GenVec, GenXys, Genzeva, Georgetown Lombardi Comprehensive Cancer Center, Georgetown University, Georgetown University Hospital, George Washington University, German Cancer Research Center, German Federal Ministry of Education and Research, Gibson Oncology, GI Innovation, Gilead Sciences, Ginkgo BioWorks, Global Cancer Technology, Global Genomics Group, GlycoT Therapeutics, Glympse Bio, Gnosis Bioresearch, GNS Healthcare, Goldfinch Bio, Google, Government of Canada, Government of South Korea, GPBio, Grail, Greater Paris University Hospitals, Greenlight Biosciences, Gretel, Gritstone Bio, GSK, Guardant Health, Gusto Global, H3 Biomedicine, Hackensack Meridian Health, Hackensack University Medical Center, Hadasit Bioholdings, Hadassah Medical Center, HalioDx, Hamad Bin Khalifa University, Hamilton Robotics, Hannover Medical School, Harvard Medical School, Harvard Stem Cell Institute, Harvard University, HAYA Therapeutics, Healix, HEALTH Biomed, Healthcare Global Enterprises, Health Sciences Research Institute Germans Trias i Pujol Foundation, Heartflow, HeartScore, Heat Biologics, Hebrew University of Jerusalem, Helen F Graham Cancer Center, Heligenics, Helix, Helmholtz Zentrum Munchen, Helomics, Henan Cancer Hospital, Hengenix Biotech, Hengrui Therapeutics, Henlius Biotech, Hennepin County Medical Center, Henry Ford Health System, Henry M. Jackson Foundation, HepaTx, Hepion Pharmaceuticals, Hereditary Neuropathy Foundation, HiberCell, Hitachi, HMNC Brain Health, Hoag Memorial Hospital Presbyterian, Homology Medicines, Horizon Discovery, Horizon Europe, Horizon Healthcare Services, Horizon Pharma plc, Hospital for Sick Children, Hospital for Special Surgery, Hoth Therapeutics, HotSpot Therapeutics, HP, HSRx Group, HTG Molecular Diagnostics, Huawei, Hudson-Alpha Institute for Biotechnology, HudsonAlpha Institute for Biotechnology, Human Cell Atlas, Human Longevity, Hummingbird Bioscience, Hummingbird Diagnostics, Huntsman Cancer Institute, IBM, IBM Watson Health, Icahn School of Medicine at Mount Sinai, Icometrix, IDbyDNA, IDEAYA Biosciences, Idengene, Ignyta, Ikena Oncology, Illumina, ILUM Health Solutions, Image Analysis, Imagene Labs, ImaginAb, Imanis Life Sciences, Imanova, Imaware, IMBdx, Imec, Imeka, IMIDomics, Immodulon Therapeutics, Immunai, ImmunArray, Immune Design, Immune Pharmaceuticals, Immunex, Immunexpress, ImmunID Technologies, Immunovia, IMPACT Therapeutics, Imperial College London, Imperial Innovations, Imugene, In-Depth Genomics, In-Q-Tel, IncellDx, Incyte, Indiana University, Indica Labs, Indivumed, IndyGeneUS AI, Information Technology for Translational Medicine, Informed Data Systems, InfYnity Biomarkers, Inivata, INmune Bio, InnoBation, Innodem Neurosciences, Innoplexus, Innosuisse, Innovate UK, Innovative Genomics Initiative (IGI), Inotrem, Inova Diagnostics, Inova Translational Medicine Institute, Inserm, InsightRX, Insitro, InSphero, Institut Curie, Institute for Genome Statistics and Bioinformatics, Institute for Systems Biology, Institute of Cancer Research, Institute of Human Genetics, Institut Gustave Roussy, Instituto Valenciano De Oncologia, Institut Pasteur, Integra, Integrated Biobank of Luxembourg, Integrated DNA Technologies, Intel, Intellia Therapeutics, Intelligence Advanced Research Projects Activity (IARPA), Intercept Pharmaceuticals, Intermountain Healthcare, Intermountain Precision Genomics, International Center for Genetic Engineering and Biotechnology, International Centers for Precision Oncology Foundation, International Myeloma Foundation, International Rice Research Institute, InterSystems, InterVenn, Intezyne, Invectys, Inventiva, inVentiv Health, inviCRO, Invitae, InVivoScribe, IO Biotech, Ionis Pharmaceuticals, ION Solutions, iPrime Therapeutics, iProgen Biotech, Ipsen, IQVIA, iReceptor Plus, Irish Haemophilia Society, IRX Therapeutics, Isogenica, IsoPlexis, ISOThrive, Israeli National Authority for Technological Innovation, iThera Medical, ITM Isotopen Technologien, IV BioHoldings, Ix Therapeutics, Jackson Laboratory, Jaguar Health, Janssen Biotech, Janssen Pharmaceuticals, Janssen Pharmaceutica NV, Janssen Research & Development, JASE Health, Jazz Pharmaceuticals, Jefferson Healthcare, Jeffrey Modell Foundation, Jiangsu Hengrui Medicine, Johns Hopkins University, Johnson & Johnson Innovation, John Wayne Cancer Institute, Jounce Therapeutics, JSR Life Sciences, Jubilant Therapeutics, Jumpcode Genomics, Juno Therapeutics, Juvenile Diabetes Research Foundation, Juventas Therapeutics, JW Biotechnology, Kahn-Sagol-Maccabi, Kaiima Bio-Agritech, Kailos Genetics, Kairos Therapeutics, Kanazawa University, Kanteron Systems, Karolinska Institute, Kartos Therapeutics, Karyopharm Therapeutics, Kayagene, Kazusa DNA Research Institute, Keck Graduate Institute of Applied Life Sciences, Keck School of Medicine of USC, Keen Eye, Keio Gijuku University, KEW, Keygene, KeyWise, Khalpey AI Lab, Kineta, King Abdullah International Research Center, KingMed Diagnostics, Kings College London, Kiromic Biopharma, Kiyatec, Kleiner Perkins Caufield & Byers, Knight Cancer Institute, Knudra Transgenics, KolGene, Konica Minolta Precision Medicine, Koye Pharmaceuticals, KPMG, Kronos Bio, Kura Oncology, Kymab, Kymera Therapeutics, Kyowa Hakko Kirin, Kytopen, Kyverna Therapeutics, L'Oreal, Laboratoire Cerba, Laboratorio Curie, Laboratory Corporation of America, La Jolla Institute for Allergy & Immunology, Lantern Pharma, Lantheus Holding, LaserGen, Latvian Institute of Organic Synthesis, Leap Therapeutics, Lee Moffitt Cancer Center, Lehigh Valley Health Network, Leibniz-Institut fur Molekulare Pharmakologie, Leica Biosystems, Lenovo, Leona M and Harry B Helmsley Charitable Trust, LEO Pharma, Lesaffre, Les Laboratoires Servier, Leukemia & Lymphoma Society, Lexent Bio, LEXEO Therapeutics, Lexogen, LGC, LGS Foundation, Lieber Institute, LifeLabs Medical Laboratory Services, LifeMap Sciences, LifeNome, LifeOmic, Life Raft Group, Li Ka Shing Foundation, Linus Biotechnology, Lipidomics Consulting, Liquid Biosciences, Liquid Biotech USA, Livongo Health, LMU University Hospital Munich, Locus Biosciences, Lodo Therapeutics, LogicBio Therapeutics, Longenesis, Lonza, Loxo Oncology, Lucid Diagnostics, Lunaphore, Lung Cancer Research Foundation, Lunit, Lupus Research Alliance, Maccabi Healthcare Services, Macrogen, Mainz Biomed, Mannin Research, MapKure, Marina Biotech, Massachusetts General Hospital, Massachusetts Institute of Technology, Mass General Brigham, Massive Bio, Mater Research, Maxim Integrated, Maxim Ventures, Mayo Clinic, MBio Diagnostics, MC10, McKesson, McMaster University, MD Anderson Cancer Center, MD Biosciences, Medaffcon, med fusion, Medgenics, MedGenome, MEDIAN Technologies, Medical College of Wisconsin, Medical Research Council, Medical University of Bialystok, Medical University of Graz, Medical University of Vienna, Medicinal Genomics, Medicines Discovery Catapult, MediciNova, MEDiC Life Sciences, Medicover, Medidata Solutions, MediSapiens, Medivation, Medivizor, MedStar Health Research Institute (MHRI), Medx, Meharry Medical College, Meiogenix, Mekonos, Memorial Sloan Kettering Cancer Center, Menarini Silicon Biosystems, Mendel Health, Merck and Co, Merck KGaA, Merrimack Pharmaceuticals, Merus, Mesh Bio, Metabolon, Metis Therapeutics, MGI Pharma, MGI Tech, Michael J Fox Foundation, Michelson Center, Michelson Diagnostic, Microba Life Sciences, Microbiotica, MicroGenDX, MicroMGx, Micronoma, Microsoft, Mie University, Milner Therapeutics Institute and Consortium, MindImmune Therapeutics, Mind Medicine, Mindstrong Health, Mirada Medical, Mirati Therapeutics, miRecule, Mirna Therapeutics, Mirnax Biosens, Miroculus, Mirus Bio, MiRXES, Mission Bio, Mission Cure, Mitra Biotech, Mitsubishi Tanabe Pharma, MOBILion Systems, Moderna, Molbio Diagnostics, Molecular Health, MolecularMD, Moleculera Labs, Mologen, Monsanto, Montreal Heart Institute, MorphoSys, Morphotek, Moss Genomics, Mount Sinai Medical Center, Mount Sinai Services, mProbe Laboratories, MRM Proteomics, Multimmune, MultiOmic Health, Multiple Myeloma Research Foundation, Multiplex Genomics, Multiply Labs, Munich Leukemia Laboratory, Muscular Dystrophy Association, Muses Labs, MyBiotics Pharma, My Care Express Merrillville, MyCartis, MyHealios, MYND Life Sciences, myNEO, My Personal Therapeutics, Myriad Genetics, Myriad RBM, Myrtelle, MyVytalics, n-Lorem Foundation, N-of-One, Namocell, NanoCellect Biomedica, NanoMab Technology, NanoString Technologies, NanoView Biosciences, NantHealth, NantKwest, NantWorks, Nanyang Technological University, Nashville Biosciences, Natera, National Cancer Center, National Cancer Center of Japan, National Cancer Center of South Korea, National Cancer Centre Singapore, National Cancer Institute, National Center for Tumor Diseases, National Comprehensive Cancer Network (NCCN), National Foundation for Cancer Research, National Geographic, National Health Service, National Heart, Lung and Blood Institute, National Human Genome Research Institute, National Institute for Health Research (NIHR), National Institute of Allergy and Infectious Diseases, National Institute of Arthritis and Musculoskeletal Diseases, National Institute of Child Health and Human Development, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of General Medical Sciences, National Institute of Mental Health, National Institute of Molecular Genetics, National Institute on Aging, National Institutes of Health, National Science Foundation, Naval Medical Research Center, Navican, Navidea Biopharmaceuticals, Navigate BioPharma Services, Navigo Proteins, Navy Medical Research Centre, Nebraska Medicine, Nebula Genomics, NEC, Negen, Nektar Therapeutics, Neochromosome, NeoDynamics, Neogap Therapeutics, Neogen, Neogenomics, Neon Therapeutics, Neoteryx, Nepean Blue Mountains Local Health District’s Nepean Hospital, Neptune Technologies & Bioressources, NervGen Pharma, Nerviano Medical Sciences, Netherlands Cancer Institute, NetraMark, Neumora Therapeutics, NeuraLight, NeurExo Sciences, NeuroGenesis, NeuroLex Laboratories, NeuroMetrix, Neuron23, NeuroPointDX, NeuroSense Therapeutics, NeuroTrauma, Newborn Screening Ontario, New England Biolabs, New Horizon Health, Newomics, NewStem, New York Genome Center (NYGC), New York Medical College, New York State Department of Health, New York University School of Medicine, Nico, Nightingale Health, Nilogen Oncosystems, NIMML Institute, NImmune Biopharma, Nitto Avecia, NMI Natural and Medical Sciences Institute, NMI TT Pharmaservices, Nomad Bioscience, Nonacus, Nordic Bioscience, Normunity, North Carolina State University, North Med, Northwell Health, Northwestern University, Notable Labs, Novartis, NovellusDx, Novigenix, Novogene, Novo Nordisk, Nrgene, Nucleai, Nucleix, NuGen Technologies, Numares, NuMedii, NuProbe, Nurosene, NuSirt, Nvidia, NxGEN MDx, NX Prenatal, NYU Grossman School of Medicine for Preclinical and Clinical Research, Octant, Odimma Therapeutics, Ohio State University, Oklahoma Medical Research Foundation, Olaris, Oligomerix, Olink Bioscience, Olink Proteomics, Olympus Respiratory America, OMAPiX, Omico, Omniome, Oncoceutics, Oncodesign, OncoDNA, OncoGenesis, Oncoheroes Biosciences, OncoHost, OncoImmunity, Oncologie, Oncology Research Information Exchange Network, Oncology Venture, OncoMed Pharmaceuticals, Oncompass Medicine, Onconova Therapeutics, Oncora Medical, OncoSec Medical, Oncoshot, OncXerna Therapeutics, One Codex, One Lambda, Oneome, OneOncology, OneThree Biotech, One Way Liver Genomics (OWL), ONK Therapeutics, Ono Pharmaceutical, Onramp Bioinformatics, Ontario Institute for Cancer Research, OpenBench, Open Commons Consortium, Open Medicine Institute, Opentrons Labworks, OpGen, Opisafe, OPKO Health, Optellum, Optina Diagnostics, OracleBio, Orchid Cellmark, Ordaos Bio, Oregon Health Sciences University, OrigiMed, Origin Agritech, Oryzon, OSE Immunotherapeutics, Oslo University Hospital, Ovid Therapeutics, Owkin, Owlstone Medical, Oxford Biodynamics, Oxford Genetics, Oxford Nanopore Technologies, Ozette Technologies, Pacific Biosciences, Pacific Northwest Research Institute, Paige, Pairwise Plants, Palantir, Panaceutics, Pan American Cancer Treatment Centers, Pancreatic Cancer Action Network, Pancreatic Cancer Collective, Pangea Biomed, Paradigm, Paragon Genomics, Parent Project Muscular Dystrophy, Parexel, Parse Biosciences, Partek, Partners HealthCare, Partner Therapeutics, PathAI, Path BioAnalytics, PathoQuest, Pathway Genomics, Patia, Paul Scherrer Institute, PAVmed, PEAR Therapeutics, Pennsylvania State University, Pepscan, PerkinElmer, Persephone Biosciences, Personal Genome Diagnostics, Personalis, Perthera, PetaGene, Pfizer, Pharmatest Services, Pharnext, Phase Genomics, Phenome Networks, Phenomix, Philips, Physiomics, PhysIQ, Pierian, PierianDx, Pierre Fabre, Pillar Biosciences, Pioneer Hi-Bred, Pionyr Immunotherapeutics, Plant Bioscience Limited, Pluristem Therapeutics, Pluristyx, Poietis, Portable Genomics, Poseida Therapeutics, PPD, Precision Biologics, Precision BioSciences, Precision Diabetes, Precision for Medicine, Precision Health Informatics, PrecisionLife, Precision NanoSystems, Precision Therapeutics, PredictImmune, Predictive Oncology, Prelude Therapeutics, Premier Inc, PreMIT, Prenetics, Prenosis, Prescient Medical, Prevacus, PreventionGenetics, PRIMA BioMed, Princess Margaret Hospital, Probiodrug, Profusa, Progentec Diagnostics, Progknowse, PrognomIQ, Prognos, Promega, Prometheus Biosciences, Prometheus Laboratories, ProMIS Neurosciences, Prophase Labs, Proscia, Prostate Cancer Clinical Trials Consortium, Prostate Cancer Foundation (PCF), Protagen, Protagonist Therapeutics, Proteic Bioscience, ProteoMediX, Proteomics International, Proteona, Proteus Genomics, Protxx, Provista Diagnostics, Pryzm Health, Psomagen, Psyche Systems, Pulmonary Fibrosis Foundation (PFF), Puma Biotechnology, Q-State Biosciences, Q2 Solutions, Qatar Foundation, Q BioMed, QED Therapeutics, Qiagen, Quadrant Biosciences, Quanterix, QuantumDx, Quantum Leap Health Care Collaborative, Queen Mary University of London, Quest Diagnostics, Quintara Biosciences, Quotient, QurAlis, R-Biopharm, R-Pharm, rAAVen Therapeutics, Race Oncology, Radius Health, Rady Children's Institute for Genomic Medicine, Rare Genomics Institute, RayBiotech, RCK, ReadCoor, Readout Health, Realm IDx, Recombia Biosciences, Redx Pharma, RefleXion Medical, Regen BioPharma, Regeneron Genetics Center, Regeneron Pharmaceuticals, Regulus Therapeutics, Related Sciences, Relay Therapeutics, Renato Dulbecco Foundation, Renji Hospital, Rensselaer Polytechnic Institute, Repare Therapeutics, Repertoire Genesis, Replicate Bioscience, Replicel Life Sciences, Repositive, Research Council of Norway, Research Institute of the Hospital Universitari Vall d'Hebron, Resolution Bioscience, Resolve Biosciences, Rett Syndrome Research Trust, Reveal Biosciences, Reveal Genomics, Revitalist Lifestyle and Wellness, Revolution Medicines, Revvity, Rheos Medicines, Rhythm Pharmaceuticals, RiboMed, Rice University, RIKEN Center for Integrative Medical Sciences, RIKEN Research Institute, Ripe Technology, Robert H. Lurie Comprehensive Cancer Center, Roche, Roche Diagnostics, Roche Molecular Systems, Rockefeller University, Rockley Photonics, Rosetta Genomics, Roswell Biotechnologies, Royal College of Surgeons (Ireland), Royal Philips Electronics, RPRD Diagnostics, RTI International, Rubicon Genomics, Rush University Medical Center, Rutgers Cancer Institute of New Jersey, Rutgers University, Rx30, RxGenomix, Ryailti, S2 Genomics, Saladax Biomedical, Salk Institute, Salud Interactiva, Sana Biotechnology, Sanford Burnham Institute, Sanford Health, Sangamo Therapeutics, Sanguine, Sanofi, Sanofi-Pasteur, Sano Genetics, Saol Therapeutics, Saphetor, Sapio Sciences, Sarah Cannon Research Institute, Sarepta Therapeutics, Scailyte, Scale Biosciences, Scandion Oncology, Scarab Genomics, Schrodinger, Science Foundation Ireland, Scipher Medicine, Sciton, Scorpion Therapeutics, Scripps Research Institute, Scripps Translational Science Institute, Secarna Pharmaceuticals, Second Genome, Seed Mena, SeLux Diagnostics, Sema4, Semmelweis University, Seneca Therapeutics, Sengenics, SEngine Precision Medicine, Sensyne Health, Sentieon, Sentinel Diagnostics, Sentinel Oncology, SenzaGen, Seoul National University, Seqster, Sequentify, SeQure Dx, SeqWell, Seracare Life Sciences, Seres Therapeutics, Serotiny, Seven Bridges Genomics, Shanghai ChemPartner, Shanghai Institutes of Preventative Medicine, Sheba Medical Center, Shenzhen Chipscreen Biosciences, Shepherd Therapeutics, Shimadzu, Shire Human Genetic Therapies, Shivom, Shuwen Biotech, Siemens, Siemens Healthineers, Silicon Biosystems, Simsen Diagnostics, Singapore Eye Research Institute (SERI), Singlera Genomics, Singleron Biotechnologies, Singular Genomics Systems, Singulex, Sirona Dx, SkylineDX, Skysong Innovations, SOLTI, SolveBio, SomaGenics, SomaLogic, Sonde Health, Sonic Healthcare, Sonrai Analytics, Sony DADC, Sookmyung Women's University, SOPHiA Genetics, Soricimed Biopharma, Sorrento Therapeutics, Spanish National Cancer Research Centre, Spark Biomedical, Spatial Genomics, Spectrum Pharmaceuticals, Spectrum Solutions, SpeeDx, Spesana, Sphingotec, SPT Labtech, SQI Diagnostics, SquareOne Wellness, SRI International, SRL, St. Jude Children's Research Hospital, Stalicla, Stallargenes, Stallergenes Greer, Stanford University, Stanford University School of Medicine, Stella Diagnostics, Stem Genomics, Stem Pharm, Step Pharma, St Jude Crosson Cancer Institute, St Luke's University Health Network of Bethlehem, Stockholm University, Strata Oncology, STRATIFYER Molecular Pathology, Streck Laboratories, Structural Genomics Consortium, Sumitovant Biopharma, Summit Therapeutics, Sunnybrook Research Institute, Sun Pharma Advanced Research Company, Sunquest Information Systems, SunTerra Biotechnology, SUNY Upstate Medical University, Supernus Pharmaceuticals, Surefire Medical, Surrey Cancer Research Institute, Susan G. Komen for the Cure, Sutro Biopharma, Swift Biosciences, Swiss Institute of Bioinformatics (SIB), Syapse, Sydys Corporation, Syncromune, SynGAP Research Fund, Syngenta, Synlogic, Synthego, Synthetic Genomics, Syros Pharmaceuticals, Sysmex, Sysmex Inostics, T-Cure Bioscience, Tabula Rasa HealthCare, Taconic Biosciences, TaiRx, Taiwan Precision Medicine Initiative, Takara Bio, Takeda Pharmaceutical, Takeda Ventures, Tampa General Hospital Cancer Institute, Tampere University Hospital, Tandem Diabetes Care, Tango Therapeutics, TapGenes, TARGET PharmaSolutions, Tasly Pharmaceuticals, Tavros Therapeutics, Taysha Gene Therapies, Tecan, Technology University Dresden, Telix Pharmaceuticals, Telo Therapeutics, Tempus, Tenet Diagnostics, TeraRecon, Terran Biosciences, Tesis Biosciences, Tessera Therapeutics, TGen Drug Development, The Cure Parkinson's Trust, The Cyprus Institute of Neurology and Genetics, The Donor Solution, The New York Stem Cell Foundation, The Parker Institute For Cancer Immunotherapy, Theralink Technologies, Theraly Fibrosis, TheraPanacea, Therapix Bio, Thermo Fisher Scientific, The Silverstein Foundation for Parkinson's, The Technical University Of Munich, The University of Chicago Medicine, Thomas Jefferson University, Thorne Research, Threshold Pharmaceuticals, Thrive Bioscience, TME Research, Tocagen, Todos Medical, Tokyo Medical and Dental University, TONIX Pharmaceuticals, Toronto Innovation Acceleration Partners, Tor Vergata University Hospital, Toshiba Medical Systems Corporation, Total Brain, Tow Foundation, Toyota Motor, TP Therapeutics, Traaser, Trakcel, Transcriptic, Transcriptome Sciences, Transgene, Transgenomic, Translational Drug Development, Translational Genomics Research Institute, Translational Software, Transmed Systems, Transnetyx, Transomic Technologies, Transplant Genomics, Travera, Trialbee, TrovaGene, TruGenomix, TScan Therapeutics, TumorGenesis, Turnstone Biologics, Tute Genomics, Twinstrand Therapeutics, Twist Bioscience, Two Blades Foundation, Tymora Analytical Operations, TypeZero Technologies, uBiome, UCB, UK Biobank, Ultima Genomics, Ultivue, Umoja Biopharma, Unilab, Unilabs, United Therapeutics, Univeristy of Durham, University Ann & Robert H. Lurie Children’s Hospital, University College London, University Health Network, University Hospital Heidelberg, University Hospital of Leuven, University Hospitals Case Medical Center, University of Adelaide, University of Alabama at Birmingham, University of Alberta, University of Arizona, University of Arkansas, University of Bern, University of Birmingham, University of Bonn, University of British Columbia, University of Buffalo, University of Calgary, University of California, University of California, Davis, University of California, San Diego, University of California, San Diego (UCSD) School of Medicine, University of California Berkeley, University of California Irvine, University of California Los Angeles, University of California San Francisco, University of California Santa Cruz, University of Chicago, University of Cincinnati, University of Colorado Denver, University of Florida, University of Greifswald, University of Heidelberg, University of Hong Kong, University of Houston, University of Illinois, University of Illinois Urbana-Champaign, University of Iowa, University of Lausanne, University of Leeds, University of Leuven, University of Ljubljana, University of Manchester, University of Maryland, University of Maryland Baltimore, University of Massachusetts, University of Melbourne, University of Miami, University of Michigan, University of Michigan Medical School, University of Minnesota, University of Nebraska, University of Newcastle, University of New South Wales, University of North Carolina, University of Ottowa, University of Oxford, University of Pennsylvania, University of Pittsburgh, University of Rochester, University of Rostock, University of Sheffield, University of Surrey, University of Sydney, University of Texas Health Science Center at Houston, University of Texas Southwestern Medical Center, University of Tokyo, University of Toronto, University of Tubingen, University of Utah, University of Verona, University of Virginia, University of Washington, University of Western Australia, University of Wisconsin, University of Wisconsin Carbone Cancer Center (UWCCC), University of Wollongong, USC Norris Comprehensive Cancer Center, US Department of Commerce, US Oncology, Utah Genome Project, Vaccinex, Valence Discovery, Vall d’Hebron Research Institute, Valo Health, Vanderbilt University, Varian Medical Systems, Vectalys, Ventana Medical Systems, Veracyte, Veravas, Veraxa Biotech, Verge Genomics, Verily, VeriSIM Life, Veritas, Veritas Genetics, Verogen, Versea Ophthalmics, Vertex Pharmaceuticals, VGI Health Technology, VIB, Vibrent Health, Victoria University, Vida Diagnostics, VieCure, ViewMind, Viewpoint Molecular Targeting, ViewRay, Viome, Vir Biotechnology, Virginia Commonwealth University, Visterra, Vitaccess, Vivante Health, Vividion Therapeutics, Viviphi, Vivo Biosciences, Vizgen, Vocalis Health, VolitionRX, Voltron Therapeutics, Voluntis, Voronoi, Voyager Therapeutics, Vyant Bio, Vyriad, Wageningen University, Washington University in St Louis, Watchmaker Genomics, Waters Corporation, WAVE Life Sciences, WaVe Lifesciences, Wearifi, Weihai Weigao Medical Devices, Weill Cornell Medical College, Wellcome Trust Sanger Institute, Wellmarker Bio, West China Hospital, Western Digital, WIN Consortium, WinterLight Labs, Wuxi Apptec Laboratory Services, WuXi NextCODE Genomics, Wuxi STA, Xcell Biosciences, xCures, Xencor, Xpressomics, Xpress Technologies, Yale Cancer Center, Yale School of Medicine, Yale University, Yeda Research and Development Company, Yield10 Bioscience, Yissum Research Development, Ymir Genomics, ZAI Laboratory, ZERO Childhood Cancer, ZS Pharma, Zymergen, Zymeworks, Zymo Research

Current Partnering reports provide insight into the trends and terms of partnering deals in the global life sciences sector.

Current Partnering reports are updated every six months to ensure the user has access to the latest announcements and trends in the topic focus of the report.

Current Partnering analysts review the deal data to provide an overview and analysis of deal trends, including example deals and terms.

Current Partnering reports source deal data from our proprietary deals and alliances database, Current Agreements. The database is updated daily by our analysts with new deals as they are announced globally by the company’s party to the deal. In addition, deal records are updated with new data as it becomes available.

The data in the Current Agreements deals and alliances database is obtained from secondary sources such as publicly available industry sources including press releases, company presentations, investor presentations, company SEC filings, other company filings, company websites, conference presentations. Sources are identified to allow for user verification.

Current Partnering provides comprehensive coverage of the following partnering or deal types:
• Asset purchase
• Assignment
• Co-development
• Co-market
• Co-promotion
• Collaborative R&D
• Contract service
• CRADA
• Cross-licensing
• Development
• Distribution
• Equity purchase
• Evaluation
• Grant
• Joint venture
• Licensing
• Loan
• Manufacturing
• Marketing
• Option
• Promotion
• Research
• Royalty financing
• Settlement
• Spin out
• Sub license
• Supply
• Termination
• Warrant

Every deal record is fully categorized and includes the following data, where available:
• Industry sector
• Therapy areas
• Technology type
• Deal components
• Financial terms
• Stage of development
• Exclusivity
• Asset type
• Geographic focus
• Excluded geography
• Company press release
• SEC filing data including contract document

All financial amounts are converted to US$ using the exchange rate available on the date of deal announcement, enabling direct comparison of deal terms across international territories.

Financial data and contract documents displayed in deal records is obtained from public sources, where disclosed by the parties to the deal.